The growing landscape of the India pharmaceuticals is witnessing significant focus on Retatrutide, a novel dual GIP and GLP-1 agonist exhibiting potential for obesity treatment . This molecule is generating considerable excitement within the healthcare community, particularly as Indian companies … Read More